Biotech · Private company
NexImmune Inc.
Track this companyFree. Adds NexImmune Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- Infusion of NEXI-001 T CellsPhase 2 · Acute Myeloid Leukemia (AML)ClinicalTrials.gov · fetched Nov 12, 2026
- NEXI-002 T CellsPhase 2 · Relapsed Refractory Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Antigen-specific T Cell Therapy for Patients With Relapsed Refractory Multiple MyelomaPHASE1_PHASE2 · SUSPENDED · started Aug 17, 2020ClinicalTrials.gov NCT04505813 · fetched Nov 12, 2026
- Antigen-specific T Cell Therapy for AML or MDS Patients With Relapsed Disease After Allo-HCTPHASE1_PHASE2 · UNKNOWN · started Feb 20, 2020ClinicalTrials.gov NCT04284228 · fetched Nov 12, 2026